MoonLake Immunotherapeutics - Class A

NEW
NAS:MLTX (Switzerland)   Class A
$ 19.05 -0.64 (-3.25%) 04:00 PM EST
At Loss
P/B:
5.41
Market Cap:
$ 1.59B
Enterprise V:
$ 1.33B
Volume:
626.69K
Avg Vol (2M):
1.19M
Trade In:
Volume:
626.69K
At Loss
Avg Vol (2M):
1.19M

MoonLake Immunotherapeutics (MLTX) Dividend

MoonLake Immunotherapeutics (MLTX) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -22.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: MLTX Dividend

Does MoonLake Immunotherapeutics (MLTX) pay a dividend?

MoonLake Immunotherapeutics (MLTX) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't MoonLake Immunotherapeutics pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. MoonLake Immunotherapeutics has returned capital to shareholders via buybacks at a rate of -22.3% over the past 3 years.

What are dividend-paying alternatives to MoonLake Immunotherapeutics?

For dividend-paying alternatives in MoonLake Immunotherapeutics's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.